Jun 14, 2019 - Top Gainers: HCHC+3.3%. EPZM +2.1%. ACA +2.1%. FVRR +1.9%. HEAR +1.6%.Top Losers: CRSP -2.9%. NEW -2.7. SGMO -2.1%. EROS -1.8%. NNBR -1.2%.
Jun 12, 2019 - Key highlights of the past week include regulatory approvals, collaborations and pipeline updates.
Jun 11, 2019 - Precision BioSciences raised over $170 million in net proceeds from its initial public offering in late March.
Jun 07, 2019 - The richest gene-editing company just got a whole lot richer.
Jun 06, 2019 - Top Gainers: ZUMZ +17.3%. BYND +14.3%. ZM +10%. CRSP +8.5%. ELGX +4%.Top Losers: DOCU -20.5%. DOMO -18.1%. OLLI -3.1%. GES -1.8%.
Jun 04, 2019 - First-quarter earnings results from three gene-editing companies gave Wall Street analysts pause.
May 31, 2019 - Vertex (VRTX) choses VX-445 triple combination regimen for global regulatory submissions to seek approval for the regimen as a treatment for cystic fibrosis based on 24-week phase III study data.
May 02, 2019 - The following slide deck was published by CRISPR Therapeutics AG in conjunction with this event.
Apr 24, 2019 - On Vertex's (VRTX) first-quarter earnings call, investor focus will be on its latest CF drug Symdeko's sales figure as well as the update on its CF triple-pill regimes.
Apr 19, 2019 - These next-generation companies are working on game-changing ways to obtain and profit from genetic insight.